Patrick Reagan
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of Brentuximab Vedotin, Rituximab, and Dose Attenuated CHP in Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) (NCT02734771) | Patrick Reagan | 2016-06-01 |
Track Patrick Reagan automatically
Every clearance here is in the API, with alerts when new ones post.